Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

REGISTER for free or LOG IN to view this content

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

TCT 2021

LAA

Up Next

Presentation TCT 2021

MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk

Presenter: Pieter Smits

November 05, 2021

More slides +

Presentation TCT 2021

Optimising Pharmacoinvasive Therapies for STEMI Patients Prior to PCI

Presenter: Robert Welsh

November 05, 2021

Presentation TCT 2021

Management of High Thrombus Burden: What Is the Role of Aspiration/ Intravenous Antipletelets/Intracoronary Lytic?

Presenter: J. Dawn Abbott

November 05, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.